Research Compound · Retatrutide 30mg

Retatrutide Research Compound —
Triple Agonist. Verified.

Retatrutide (GLP-3RT) — investigational triple GIP/GLP-1/glucagon receptor co-agonist. The most comprehensive incretin agonist in preclinical research. 30mg lyophilized, HPLC verified.

≥98% HPLC PurityMass Spec VerifiedLyophilized · 30mgCOA IncludedUSA Operations

Order Retatrutide 30mg — $240.00 Read the research guide

$240.00

per 30mg vial

In Stock

Order Retatrutide 30mg

COA included with every order
For laboratory research use only

HPLC Verified≥98% purity confirmed per lot

COA IncludedLot-specific certificate ships with order

Mass Spec IDMolecular identity confirmed per batch

USA OperationsVerified sourcing. Documented chain.

About This Compound

What Is Retatrutide 30mg?

Retatrutide is a synthetic peptide triple agonist targeting three receptors simultaneously: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors. Developed by Eli Lilly, it represents the most comprehensive incretin pharmacology in a single compound — adding glucagon receptor agonism to the dual incretin approach pioneered by Tirzepatide.

In preclinical and early clinical research, Retatrutide is studied for its ability to stimulate all three metabolic hormone pathways simultaneously, enabling investigation of glucagon’s role in energy expenditure alongside GIP and GLP-1 incretin effects. The 30mg format is suitable for labs requiring higher volumes across extended research protocols.

For a full breakdown of the research literature, read our Retatrutide 30mg research guide →

// compound profile

CompoundRetatrutide (GLP-3RT)

ClassTriple GIP/GLP-1/glucagon agonist

TargetsGIPR, GLP-1R, GcgR

FormLyophilized powder

Size30mg per vial

Purity≥98% HPLC

What Sets Us Apart

We Verify Before We Ship.

CoreVionRX doesn’t manufacture peptides. What we do — rigorously — is verify every batch before it reaches our catalog.

≥98%

Purity by Reversed-Phase HPLC

HPLC separates the compound from any impurities and measures the exact purity percentage. The chromatogram is documented on your COA.

MS/MS

Mass Spectrometry Identity Check

Electrospray ionization mass spectrometry verifies the molecular weight matches the compound specification. Confirms you’re getting the actual compound.

Lot #

Lot-Specific Certificate of Analysis

Your COA is tied to your specific production lot — not a generic document. This is not standard practice in this market. We made it one anyway.

100%

Documented Before Listing

No compound reaches our catalog without clearing our verification process first. If documentation isn’t available for a batch, that batch doesn’t ship.

Technical Specifications

Full Product Data

Everything you need to evaluate this compound for your research protocol.

Specification	Value
Compound	Retatrutide (GLP-3RT)
Class	Triple receptor co-agonist
Receptor Targets	GIP receptor (GIPR), GLP-1 receptor (GLP-1R), Glucagon receptor (GcgR)
Form	Lyophilized powder
Vial Size	30mg per vial
Purity	≥98% by reversed-phase HPLC
Identity	Confirmed by electrospray ionization mass spectrometry
Storage (lyophilized)	−20°C, protected from light and moisture
Storage (reconstituted)	2–8°C, away from light
Documentation	Lot-specific COA with HPLC chromatogram — included with every order

Preclinical Research

What Researchers Study Retatrutide 30mg For

All published research is preclinical — cell cultures and animal models. No human clinical trial data exists for Retatrutide 30mg. Here’s where the science currently stands.

Triple Receptor Agonism Research

Retatrutide enables simultaneous investigation of GIP, GLP-1, and glucagon receptor pharmacology. Research examines how triple co-agonism produces outcomes distinct from dual (Tirzepatide) or single (semaglutide) agonists.

Jastreboff AM. et al. (2023) N Engl J Med 389(6):514-26

Glucagon Receptor Pathway Studies

The addition of glucagon receptor agonism to GIP/GLP-1 activity is Retatrutide’s defining research feature. Studies examine glucagon’s role in hepatic glucose production, energy expenditure, and lipolysis when activated alongside incretin pathways.

Samms RJ. et al. (2023) Cell Metab 35(9):1517-33

Comparative Incretin Biology

Retatrutide is a valuable pharmacological tool for understanding incretin hierarchy — comparing the contributions of GIP, GLP-1, and glucagon to metabolic regulation, both individually and in combination.

Coskun T. et al. (2022) Mol Metab 66:101634

Why CoreVionRX

Documentation Is the Product.

Most peptide vendors claim purity. We document it. Every compound ships with independent lab verification — not because regulations require it, but because you deserve to know exactly what you’re working with.

Independent HPLC Testing

Every batch runs through reversed-phase HPLC before we list it. The chromatogram appears on your COA. Verify the peak profile yourself.

Lot-Specific Documentation

Your COA is tied to your production lot — not a template document. “COA available upon request” is not how we operate.

Transparent About What We Are

We source and verify. We are not a synthesis lab. That honesty is deliberate — it’s the only way to build a brand worth buying from twice.

Lyophilized for Stability

Ships as lyophilized powder — stable at −20°C for 24+ months. Full integrity maintained until you’re ready to reconstitute.

Common Questions

Straight Answers.

What is Retatrutide and how does it differ from Tirzepatide?

Retatrutide is a triple receptor agonist — it activates GIP, GLP-1, and glucagon receptors simultaneously. Tirzepatide is a dual agonist (GIP + GLP-1 only). Retatrutide adds glucagon receptor agonism, which plays a distinct role in hepatic glucose production and energy expenditure research.

What is GLP-3RT?

GLP-3RT is CoreVionRX’s catalog designation for Retatrutide — the triple GLP receptor compound. The three target receptors are the GIP receptor (GIPR), GLP-1 receptor (GLP-1R), and glucagon receptor (GcgR).

What research areas use Retatrutide?

Research focuses on triple incretin receptor pharmacology, comparative metabolic biology (vs Tirzepatide and GLP-1 agonists), hepatic glucose regulation, energy expenditure pathways, and adipose tissue biology. Clinical phase trial data has been published, making it relevant for translational research.

How do I reconstitute Retatrutide?

Reconstitute with bacteriostatic water. Inject water slowly down the vial wall, swirl gently. Use our reconstitution calculator for exact volumes based on your target concentration and experimental design.

How should Retatrutide be stored?

Store lyophilized at −20°C, protected from light and moisture. After reconstitution, store at 2–8°C away from light. The 30mg format suits labs running multi-experiment protocols with larger volume requirements.

Continue Your Research

Related Resources

Ready to Order Retatrutide 30mg?

In stock. COA included. HPLC + mass spec verified. Ships with full documentation.

Order Retatrutide 30mg — $240.00 Browse All Compounds

≥98% HPLC PurityLot-Specific COAMass Spec VerifiedUSA Operations

For laboratory research use only. Not for human or animal consumption.
CoreVionRX supplies research compounds to qualified laboratories and research institutions.

Retatrutide Research Compound —Triple Agonist. Verified.